155 related articles for article (PubMed ID: 37868825)
41. Molecular Features, Prognostic Value, and Cancer Immune Interactions of Angiogenesis-Related Genes in Ovarian Cancer.
Ji Y; Ge Q; Zhang W; Qu P
Reprod Sci; 2023 May; 30(5):1637-1650. PubMed ID: 36471217
[TBL] [Abstract][Full Text] [Related]
42. Single-cell transcriptomics identify TNFRSF1B as a novel T-cell exhaustion marker for ovarian cancer.
Gao Y; Shi H; Zhao H; Yao M; He Y; Jiang M; Li J; Li Z; Su S; Liu T; Yin C; Liao X; Yue W
Clin Transl Med; 2023 Sep; 13(9):e1416. PubMed ID: 37712139
[TBL] [Abstract][Full Text] [Related]
43. Signatures of tumor-associated macrophages correlate with treatment response in ovarian cancer patients.
Gao Y; Qi Y; Shen Y; Zhang Y; Wang D; Su M; Liu X; Wang A; Zhang W; He C; Yang J; Dai M; Wang H; Cai H
Aging (Albany NY); 2024 Jan; 16(1):207-225. PubMed ID: 38175687
[TBL] [Abstract][Full Text] [Related]
44. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
45. Construction of an Immune Cell Infiltration Score to Evaluate the Prognosis and Therapeutic Efficacy of Ovarian Cancer Patients.
Liu J; Wang Y; Yuan S; Wei J; Bai J
Front Immunol; 2021; 12():751594. PubMed ID: 34745124
[TBL] [Abstract][Full Text] [Related]
46. Developing four cuproptosis-related lncRNAs signature to predict prognosis and immune activity in ovarian cancer.
Liu L; Wang Q; Zhou JY; Zhang B
J Ovarian Res; 2023 Apr; 16(1):88. PubMed ID: 37122030
[TBL] [Abstract][Full Text] [Related]
47. Identification and validation of an immune-related lncRNAs signature to predict the overall survival of ovarian cancer.
Li H; Liu ZY; Chen YC; Zhang XY; Wu N; Wang J
Front Oncol; 2022; 12():999654. PubMed ID: 36313727
[TBL] [Abstract][Full Text] [Related]
48. CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer.
Hua T; Liu DX; Zhang XC; Li ST; Yan P; Zhao Q; Chen SB
Front Immunol; 2023; 14():1151109. PubMed ID: 37063862
[TBL] [Abstract][Full Text] [Related]
49. Identification and Validation of Angiogenesis-Related Gene Expression for Predicting Prognosis in Patients With Ovarian Cancer.
Wang Y; Li BX; Li X
Front Oncol; 2021; 11():783666. PubMed ID: 35047401
[TBL] [Abstract][Full Text] [Related]
50. A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer.
Xu X; Wu Y; Jia G; Zhu Q; Li D; Xie K
J Ovarian Res; 2023 Jan; 16(1):5. PubMed ID: 36611197
[TBL] [Abstract][Full Text] [Related]
51. An Integrative Analysis Revealing ZFHX4-AS1 as a Novel Prognostic Biomarker Correlated with Immune Infiltrates in Ovarian Cancer.
Huang C; Cui H; Lang X; Zhao F
J Immunol Res; 2022; 2022():9912732. PubMed ID: 35795530
[TBL] [Abstract][Full Text] [Related]
52. Identification of Hypoxia Signature to Assess the Tumor Immune Microenvironment and Predict Prognosis in Patients with Ovarian Cancer.
Wei C; Liu X; Wang Q; Li Q; Xie M
Int J Endocrinol; 2021; 2021():4156187. PubMed ID: 34950205
[TBL] [Abstract][Full Text] [Related]
53. Machine learning-based integration develops an immune-related risk model for predicting prognosis of high-grade serous ovarian cancer and providing therapeutic strategies.
Wu Q; Tian R; He X; Liu J; Ou C; Li Y; Fu X
Front Immunol; 2023; 14():1164408. PubMed ID: 37090728
[TBL] [Abstract][Full Text] [Related]
54. Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.
Liu J; Xu W; Li S; Sun R; Cheng W
Int J Med Sci; 2020; 17(18):3200-3213. PubMed ID: 33173439
[No Abstract] [Full Text] [Related]
55. Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response.
Chen J; Chen S; Dai X; Ma L; Chen Y; Bian W; Sun Y
Front Immunol; 2022; 13():1007326. PubMed ID: 36189254
[TBL] [Abstract][Full Text] [Related]
56. Ovarian Cancer Risk Scores Based on Immune-Related Pseudogenes to Predict Overall Survival and Guide Immunotherapy and Chemotherapy.
Zhao J; Zhao R; Wei X; Jiang X; Su F
Evid Based Complement Alternat Med; 2021; 2021():1586312. PubMed ID: 34659427
[TBL] [Abstract][Full Text] [Related]
57. The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit.
Hou Y; Qiao S; Li M; Han X; Wei X; Pang Y; Mao H
Front Genet; 2022; 13():1090640. PubMed ID: 36704336
[TBL] [Abstract][Full Text] [Related]
58. Comprehensive analysis of the interaction of antigen presentation during anti-tumour immunity and establishment of AIDPS systems in ovarian cancer.
Sun W; Xu P; Gao K; Lian W; Sun X
J Cell Mol Med; 2024 Apr; 28(8):e18309. PubMed ID: 38613345
[TBL] [Abstract][Full Text] [Related]
59. Glycosylation-Related Genes Predict the Prognosis and Immune Fraction of Ovarian Cancer Patients Based on Weighted Gene Coexpression Network Analysis (WGCNA) and Machine Learning.
Zhao C; Xiong K; Zhao F; Adam A; Li X
Oxid Med Cell Longev; 2022; 2022():3665617. PubMed ID: 35281472
[TBL] [Abstract][Full Text] [Related]
60. Construction and validation of a novel aging-related gene signature and prognostic nomogram for predicting the overall survival in ovarian cancer.
Liu L; Zhao J; Du X; Zhao Y; Zou C; Zhou H; Li W; Yan X
Cancer Med; 2021 Dec; 10(24):9097-9114. PubMed ID: 34825509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
